ChromaDex (CDXC) Earnings Date, Estimates & Call Transcripts Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ChromaDex Earnings Summary Upcoming Q4 Earnings DateMay. 6After Market ClosesEstimatedConsensus EPS (Oct. 31) $0.01 Actual EPS (Oct. 31) $0.02 Beat By $0.02 Actual Revenue (Oct. 31) $25.58MChromaDex released Q3 2024 earnings on October 31, 2024, reporting an EPS of $0.02, which beat analysts' consensus estimates of $0.01 by $0.02. Quarterly revenue was reported to be $25.58 million, above analyst estimates of $23.70 million. With a trailing EPS of $0.10 and a P/E Ratio of 787.29, ChromaDex's earnings are expected to grow 200.00% next year, from $0.04 to $0.12 per share. Q3 2024 Earnings ResourcesQ3 2024 Earnings ReportConference Call Transcript & Audio Slide Deck Press Release (8-K) Quarterly Report (10-Q)CDXC Upcoming EarningsChromaDex's next earnings date is estimated for Tuesday, May 6, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get ChromaDex Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ChromaDex and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCDXC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CDXC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads ChromaDex Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252$0.00$0.03$0.02Q2 20252$0.01$0.04$0.03Q3 20252$0.02$0.04$0.03Q4 20252$0.03$0.06$0.05FY 20258$0.06$0.17$0.12Q1 20262$0.01$0.05$0.03Q2 20262$0.02$0.06$0.04Q3 20262$0.04$0.08$0.06Q4 20262$0.06$0.11$0.09FY 20268$0.13$0.30$0.22 Remove Ads ChromaDex Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)--------10/31/2024Q3 2024$0.0050$0.02+$0.0150$0.02$23.70M$25.58M5/8/2024Q1 2024-$0.03-$0.01+$0.02-$0.01$22.35M$22.15M11/8/2023Q3 2023-$0.03-$0.01+$0.02-$0.01$20.61M$19.50M8/9/2023Q2 2023-$0.04-$0.03+$0.01-$0.03$19.49M$20.32M5/10/2023Q1 2023-$0.05-$0.03+$0.02-$0.03$19.37M$22.56M ChromaDex Earnings - Frequently Asked Questions When is ChromaDex's earnings date? ChromaDex has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on CDXC's earnings history. What guidance has ChromaDex issued on next quarter's earnings? ChromaDex issued an update on its FY 2025 earnings guidance on Tuesday, March, 4th. The company issued revenue guidance of $117.5 million-$117.5 million, compared to the consensus revenue estimate of $118.3 million. Did ChromaDex beat their earnings estimates last quarter? In the previous quarter, ChromaDex (NASDAQ:CDXC) reported $0.02 earnings per share (EPS) to beat the analysts' consensus estimate of $0.01 by $0.02. Learn more on analysts' earnings estimate vs. CDXC's actual earnings. How can I listen to ChromaDex's earnings conference call? The conference call for ChromaDex's latest earnings report can be listened to online. Listen to Conference Call How can I read ChromaDex's conference call transcript? The conference call transcript for ChromaDex's latest earnings report can be read online. Read Transcript How much revenue does ChromaDex generate each year? ChromaDex (NASDAQ:CDXC) has a recorded annual revenue of $99.60 million. How much profit does ChromaDex generate each year? ChromaDex (NASDAQ:CDXC) has a recorded net income of -$4.94 million. CDXC has generated $0.10 earnings per share over the last four quarters. What is ChromaDex's price-to-earnings ratio? ChromaDex (NASDAQ:CDXC) has a trailing price-to-earnings ratio of 787.29. What is ChromaDex's EPS forecast for next year? ChromaDex's earnings are expected to grow from $0.04 per share to $0.12 per share in the next year, which is a 200.00% increase. More Earnings Resources from MarketBeat Related Companies Apellis Pharmaceuticals Earnings Results Twist Bioscience Earnings Results MoonLake Immunotherapeutics Earnings Results Amneal Pharmaceuticals Earnings Results Recursion Pharmaceuticals Earnings Results Vericel Earnings Results Mirum Pharmaceuticals Earnings Results Schrödinger Earnings Results Denali Therapeutics Earnings Results Metsera Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NASDAQ:CDXC) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ChromaDex Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share ChromaDex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CDXC Stock Free CDXC Stock Alerts